Objective: To explore the effects of SANPAOCAO (SPC), a compound traditional Chinese folk medicine, on chronic dermatitis/eczema in mice induced by 2, 4-dinitrochlorobenzene (DNCB).
Introduction
Atopic dermatitis (AD) is a clinical syndrome that is characterized by pruritic skin lesions that are distinguished by infiltrating lymphocytes, macrophages and granulated mast cells. 1, 2 AD is a common disease with an increasing incidence in industrialized countries and is a genotypic diathesis in which minor skin stimulation is perceived as an itching and, when scratched or rubbed, elicits a heightened immune response. [3] [4] The heightened immune response leads to the development of eczema, which is the clinical syndrome of the eczematous dermatitis group of inflammatory skin conditions characterized by pruritus, pale, erythematous and violaceous hues, vesiculation, erosion, scaling, exudation, crusting, lichenification, and excoriations. [5] [6] Although topical steroid therapy is used to manage this disease, many patients suffer from serious side effects of steroid ointments. [7] [8] Hence, a great deal of effort has been directed toward identifying safer compounds or herbal remedies that can inhibit the development of atopic dermatitis.
Some traditional Chinese herbal prescriptions, such as luteolin and white paeony root, have been clinically applied as curative agents against incurable chronic diseases. [9] [10] Sanpaocao (SPC) is widely used in the Hannan province of China for the treatment of dermatitis. SPC is a decoction consisting of three tropical medicinal plants, Cardiospermum halicacabum, Physalis minima and Jussiaea repens. This study investigated the protective effect of SPC with regard to the development of dermatitis in Balb/c mice that had been topically challenged with 1-chloro-2, 4-dinitrobenzene (DNCB). The effect of Sanpaocao on thymus activation regulated chemokine (TARC) production in the keratinocyte cell line, HaCaT, was also examined to elucidate a possible mechanism for the anti-dermatitic effects of SPC.
Methods

Mice
The Institutional Animal Care and Utilization Committee of Hainan Medical University approved all animal procedures. Male Balb/c (weighing 20g) were purchased from Experimental Animals Co.(Guangdong, China), placed in cages at a temperature between 20 and 23℃ with a 12 hour light and dark cycle and a relative humidity of 50%. Animals were given commercial mouse chow (Hainan, China) and water ad libitum. Twenty-five microliters of 0.1% DNCB in acetone and olive oil (3: 1) was applied to each side of the right ears and dorsal skin three times per week (Monday, Wednesday and Friday) for 5 weeks. Mice were then housed for 3 days without any further treatment. There were seven treatment groups: a negative control group (DNCB (-)), a positive control group (DNCB (+)), a prednisolone group (DNCB (+) prednisolone), an SPC ethanol extract group (DNCB (+)SPC), a C. halicacabum ethanol extract group (DNCB (+) C.halicacabum), a Ph. minima ethanol extract group (DNCB (+)Ph.minima) and a J. repens ethanol extract group (DNCB (+) J.repens). Each ethanol extract treated group was treated orally at a dose of 100mg/kg/d and the prednisolone group was given a dose of 30mg/kg/d (3 times per week for 5 weeks) in their drinking water. Control animals received the vehicle only. Mice were sacrificed 38 days after first applying the DNCB) and blood was collected from the vena cava. Skin tissues from the backs of the mice and their ears were excised and subjected to histological examination.
Preparation the ethanol extract
Three medicinal plants were collect from the outskirts of Haikou, Hainan Province, China，and was authenticated by Doctor Kainian Cen, Hainan Medical University. The air-dried and ground aerial parts of Sanpaocao (C. halicacabum 200 g Ph. minima 200 g J. repens. 120g), C. halicacabum (200 g), Ph. minima (200 g) , and J. repens (200 g ) were extracted with 70% ethanol (EtOH, 3 times W/V) using maceration for 3 days with 90rmp shaking at 40℃, repeated three times. The extract was filtered through a cotton bed followed by Whatman No. 1 filterpaper. The filtrate was evaporated under reduced pressure at 45°C using a Buchii Rotaroy Evaporator to leave a gummy concentrate and through vacuum drying to produce Sanpaocao ethanol extract (73.54g), C. halicacabum ethanol extract (23.88g), Ph. minima ethanol extract (31.21g), and J. repens ethanol extract (16.59g).
Enzyme Linked Immunosorbent Assay (ELISA)
Total serum Ig E levels were measured by ELISA. Blood samples were collected 24 hours after the fifth application of DNCB and Ig E concentrations in serum were quantified using BD OptEIATM Set Mouse Ig E ELISA kits (BD Pharmingen, CA, U.S.A). In brief, a 1: 250 dilution of anti-mouse Ig E monoclonal antibody in PBS was placed in each well of an immunoplate (Corning 3590 96-well EIA/RIA plate, Corning, NY, U.S.A.) and maintained overnight at 4 °C. After washing the wells with PBS containing 0.05% Tween 20 (washing buffer) 3 times, 200ml of PBS containing 1% bovine serum albumin (BSA in PBS) was placed in each well. After 1 h at room temperature, wells were washed three times with washing buffer and 100ml aliquots of serum samples diluted 30-50 fold with BSA in PBS were placed in the wells. After further incubation for 1 h at room temperature, wells were again washed five times with washing buffer, 100ml of streptavidin-horseradish peroxideconjugated detection antibody (SAv-HRP) diluted 250-fold with washing buffer was then added, and the plate left for one hour at room temperature. After washing 7 times with washing buffer, the enzyme reaction was initiated by adding 100m l of substrate solution (0.1 M citric acid, 0.2 M Na2HPO4, ophenylene diamine and H 2 O 2 ), and the plate was left for 30 minutes at room temperature. The reaction was terminated by adding 50ml of 1 M H 2 SO 4 to each well and absorbance at 450 nm was measured immediately using an ELISA reader (EL800) (BioTek, VT, U.S.A.).
Histopathologic Examination
Ear tissues were isolated from each mouse and fixed in 10% formalin in 50mM of a phosphate buffer (pH 7.0) for 24 hours at 4℃. Ear tissues were subsequently embedded in paraffin, sectioned (4 mm), stained with Hematoxylin and Eosin, and examined by optical microscopy (Olympus, Tokyo, Japan). A certified pathologist analyzed and scored the samples in a blinded manner. A minimum of 2 sections per experimental animal were examined for the presence and degree of incrustation, thickening of the epidermis, epidermal necrosis, bleeding, hyperkeratosis and inflammation of the epidermis and dermis.
Statistical Analysis
Results were expressed as means±S.E. (S.E.M.). The significances of andy differences were evaluated using Students's t-test. Differences between experimental groups were evaluated using analysis of variance. Values of p < 0.05 were accepted as significant.
Results
Ear Swelling Inhibition by SPC or Prednisolone
After the fourth and fifth DNCB applications, right ear swelling and thickening was evident, different degrees. It was most obvious in the DNCB (+) groups, but the daily administration of SPC or prednisolone significantly inhibited the degree of swelling (Figure 1 ). Table 1 shows that the SPC group and prednisolone group mice right ear weight were 2.80 g and 3.07 g, respectively, whereas the positive controls weighed as much as 11.23 g.
Histological analysis
Balb/c mice have been previously shown to develop AD-like skin lesions after the repeated topical application of DNCB under SPF conditions, and in the present study Balb/c mice were used to investigate the preventative effect of AM in this context. Symptom severity in Balb/c mice was found to increase gradually with time during the 5-week DNCB challenge period. Oral SPC (100 mg/kg/d) suppressed AD-like skin lesion development, and, as expected, prednisolone (30 mg/kg/d) significantly inhibited the development of skin lesions, but in the other groups there were no obvious treatment effects. Photographs showed that SPC and prednisolone effectively treated AD-like lesion induced by DNCB on mice. These groups showed broader recovery from AD-like lesions and hair growth on the dorsal skin ( Figure 1 ). Histological examination of the skin lesion showed no abnormal changes in the control group, whereas in the DNCB (+) group, the Ph.minima group, the 
SPC Did Inhibit DNCB-Induced Serum Ig E Level Elevation
After completing DNCB treatment, serum samples were obtained and total Ig E levels were determined by ELISA. Serum Ig E levels were markedly increased by DNCB (Figure 2 ). Oral SPC inhibited this DNCB-induced serum Ig E increase, as did prednisolone.
This study shows that SPC can reduce the severity of dermatitis-like skin lesions induced by topical DNCB in Balb/c mice. DNCB-treated Balb/c mice developed skin lesions characterized by erythema, edema, excoriation, and scaling, and histologically by massive inflammatory cell infiltration, which are similar to those reported for Balb/c mice maintained under conventional conditions. 1 Moreover, oral SPC, like prednisolone, administered to DNCB-treated Balb/c mice clearly inhibited the development of AD-like skin lesions.
The upregulation of total serum IgE is a hallmark of atopic dermatitis. Th2-type cytokine IL-4 increases the switching of B cells from Ig M to Ig E production. 4 Accordingly, total serum Ig E was found to be significantly increased following repeated DNCB treatment in Balb/c mice ( Figure 2) . These results highlight the protective effects of SPC on the development of dermatitis in DNCB-applied mice. The topical application of DNCB on the backs of mice was an efficient tool for inducing severe and controlled dermatitis within 5 weeks.
The three plant materials used contain several chemicals with anti-allergic and anti-inflammatory activity. [11] [12] [13] These include physalin, flavonoids, lignans and catechins in the plant sources of SPC.However, it is impossible to isolate all the active constituents from SPC. Through this experiment, we found that only three plants crude extract mixed together of have a beneficial effect in inhibiting chronic dermatitis. Therefore, SPC contain many compounds from three medicinal plant sources, and the structures of components might change into new or modified compounds during the mixed ethanol extraction. Alternatively, several compounds from different plants may need to be combined together to have the treatment effect. It is uncertain changes are induced by ethanol extraction, and which elements elements play a role in the treatment process, and so more research is needed.
Balb/c mice topically treated with DNCB were used to determine the anti-dermatitic effect of SPC in vivo. The oral administration of SPC effectively prevented development of dermatitis, as evidenced by histology examination. Moreover, ELISA assay results confirmed that SPC treatment inhibited the increase in serum IgE level normally induced by DNBC. SPC is often prescribed to patients with atopic dermatitis in Chinese folk medicine, and these results provide the necessary scientific evidence of its clinical efficacy.
In conclusion, the oral administration of SPC extracts was found to inhibit the development of AD-like skin lesions in Balb/c mice treated repeatedly with DNCB. 
